Vancomycin-resistant Staphylococcus aureus risk factors: Difference between revisions

Jump to navigation Jump to search
Hardik Patel (talk | contribs)
Created page with "__NOTOC__ {{Vancomycin-resistant Staphylococcus aureus}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn..."
 
WikiBot (talk | contribs)
m Changes made per Mahshid's request
 
(One intermediate revision by one other user not shown)
Line 6: Line 6:


==Overview==
==Overview==
Persons with underlying health conditions (such as [[diabetes]] and kidney disease), previous infections with methicillin-resistant Staphylococcus aureus ([[MRSA]]), tubes going into their bodies (such as intravenous [IV] catheters), recent hospitalizations, and recent exposure to [[vancomycin]] and other antimicrobial agents are at increased risk of developing VISA and VRSA infections.
Persons with underlying health conditions (such as [[diabetes]] and kidney disease), previous infections with methicillin-resistant Staphylococcus aureus ([[MRSA]]), tubes going into their bodies (such as intravenous catheters), recent hospitalizations, and recent exposure to [[vancomycin]] and other antimicrobial agents are at increased risk of developing VISA and VRSA infections.


==References==
==References==
Line 13: Line 13:
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
 
[[Category:Staphylococcaceae]]
[[Category:Staphylococcaceae]]
[[Category:Bacterial diseases]]
[[Category:Bacterial diseases]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 19:07, 18 September 2017

Vancomycin-resistant Staphylococcus aureus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vancomycin-resistant Staphylococcus aureus risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vancomycin-resistant Staphylococcus aureus risk factors

CDC on Vancomycin-resistant Staphylococcus aureus risk factors

Vancomycin-resistant Staphylococcus aureus risk factors in the news

Blogs on Vancomycin-resistant Staphylococcus aureus risk factors

Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus

Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Persons with underlying health conditions (such as diabetes and kidney disease), previous infections with methicillin-resistant Staphylococcus aureus (MRSA), tubes going into their bodies (such as intravenous catheters), recent hospitalizations, and recent exposure to vancomycin and other antimicrobial agents are at increased risk of developing VISA and VRSA infections.

References

Template:WH Template:WS